Combination Chemotherapy for Metastatic Breast Cancer
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the objective tumor response of the first-line
therapy combination of gemcitabine and cisplatin in patients with metastatic breast cancer